Cannabinoid derivatives and their use
Provided herein are methods of using a compound of Formula (I) or pharmaceutically acceptable salt thereof, for example, in the treatment of a mental health disorder or chronic inflammatory disease.
1. A compound having the structure:
2. A pharmaceutical composition comprising the compound of claim 1 , and a pharmaceutically acceptable carrier.
3. A method of treating a chronic inflammatory disease in a subject in need thereof, the method comprising administering to the subject the compound of claim 1 , wherein the chronic inflammatory disease is an inflammatory bowel disease.
4. The method of claim 3 wherein the inflammatory disease is Crohn's disease.
5. The method of claim 3 , wherein the inflammatory disease is ulcerative colitis.
6. The method of claim 3 , wherein the compound is administered orally.
7. A method of treating epilepsy in a subject in need thereof, the method comprising administering to the subject the compound of claim 1 .
8. A method of treating seizure in a subject in need thereof, the method comprising administering to the subject the compound of claim 1 .